Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein

Journal of Immunology

Volumn 175, Issue 3, 2005, Pages 1974-1982

  O'Connor, Kevin C ^a,f   Appel, Heiner ^c,f   Bregoli, Lisa ^a   Call, Matthew E ^c,f   Catz, Ingrid ^d   Chan, Jennifer A ^b,f   Moore, Nicole H ^a   Warren, Kenneth G ^d   Wong, Susan J ^e   Hafler, David A ^a,f   Wucherpfennig, Kai W ^c,f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e WADSWORTH CENTER   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE; IMMUNOGLOBULIN G; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ANTIBODY PRODUCTION; ARTICLE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DEMYELINATION; ENCEPHALITIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; MALE; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 22544453860     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.3.1974     Document Type: Article

References (61)

1. Kuchroo, V. K., A. C. Anderson, H. Waldner, M. Munder, E. Bettelli, and L. B. Nicholson. 2002. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20: 101-123.
2. Wolf, S. D., B. N. Dittel, F. Hardardottir, and C. A. Janeway, Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184: 2271-2278.
3. Lafaille, J. J., K. Nagashima, M. Katsuki, and S. Tonegawa. 1994. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78: 399-408.
4. McMahon, E. J., S. L. Bailey, C. V. Castenada, H. Waldner, and S. D. Miller. 2005. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11: 335-339.
5. Schluesener, H. J., R. A. Sobel, C. Linington, and H. L. Weiner. 1987. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139: 4016-4021.
6. Piddlesden, S. J., H. Lassmann, F. Zimprich, B. P, Morgan, and C. Linington. 1993. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am. J. Pathol. 143: 555-564.
7. Raine, C. S., B. Cannella, S. L. Hauser, and C. P. Genain. 1999. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann. Neurol. 46: 144-160.
8. Genain, C. P., M. H. Nguyen, N. L. Letvin, R. Pearl, R. L. Davis, M. Adelman, M. B. Lees, C. Linington, and S. L. Hauser. 1995. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J. Clin. Invest. 96: 2966-2974.
9. Storch, M. K., S. Piddlesden, M. Haitia, M. Iivanainen, P. Morgan, and H. Lassmann. 1998. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann. Neurol. 43: 465-471.
10. Genain, C. P., B. Cannella, S. L. Hauser, and C. S. Raine. 1999. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5: 170-175.
11. O'Connor, K. C., A. Bar-Or, and D. A. Hafler. 2001. The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. J. Clin. Immunol. 21: 81-92.
12. Cross, A. H., J. L. Trotter, and J. Lyons. 2001. B cells and antibodies in CNS demyelinating disease. J. Neuroimmunol. 112: 1-14.
13. Rabat, E. A., D. A. Freedman, J. P. Murray, and V. Knaub. 1950. A study of the crystalline albumin, γ globulin and the total protein in the cerebrospinal fluid of one hundred cases of multiple sclerosis and other diseases. Am. J. Med. Sci. 219: 55-64.
14. Lowenthal, A., M. Van Sande, and D. Karcher. 1960. The differential diagnosis of neurological diseases by fractionating electrophoretically the CSF G-globulins. J. Neurochem. 235: 229-233.
15. Johnson, K. P., S. C. Arrigo, B. J. Nelson, and A. Ginsberg. 1977. Agarose electrophoresis of cerebrospinal fluid in multiple sclerosis: a simplified method for demonstrating cerebrospinal fluid oligoclonal immunoglobulin bands. Neurology 27: 273-277.
16. Esiri, M. M. 1977. Immunoglobulin-containing cells in multiple-sclerosis plaques. Lancet 2: 478-480.
17. Prineas, J. W., and R. G. Wright. 1978. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest. 38: 409-421.
18. Mehta, P. D., S. Frisch, H. Thormar, W. W. Tourtellotte, and H. M. Wisniewski. 1981. Bound antibody in multiple sclerosis brains. J. Neurol. Sci. 49: 91-98.
19. Lock, C., G. Hermans, R. Pedotti, A. Brendolan, E. Schadt, H. Garren, A. Langer-Gould, S. Strober, B. Cannella, J. Allard, et al. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8: 500-508.
20. Corcione, A., S. Casazza, E. Ferretti, D. Giunti, E. Zappia, A. Pistorio, C. Gambini, G. L. Mancardi, A. Uccelli, and V. Pistoia. 2004. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA 101: 11064-11069.
21. H4 germline segments in an acute multiple sclerosis brain. Ann. Neurol. 43: 236-243.
22. Baranzini, S. E., M. C. Jeong, C. Butunoi, R. S. Murray, C. C. Bernard, and J. R. Oksenberg. 1999. B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J. Immunol. 163: 5133-5144.
23. Smith-Jensen, T., M. P. Burgoon, J. Anthony, H. Kraus, D. H. Gilden, and G. P. Owens. 2000. Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response. Neurology 54: 1227-1232.
24. Williamson, R. A., M. P. Burgoon, G. P. Owens, O. Ghausi, E. Leclerc, L. Firme, S. Carlson, J. Corboy, P. W. Parren, P. P. Sanna, et al. 2001. Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc. Natl. Acad. Sci. USA 98: 1793-1798.
25. Owens, G. P., A. M. Ritchie, M. P. Burgoon, R. A. Williamson, J. R. Corboy, and D. H. Gilden. 2003. Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J. Immunol. 171: 2725-2733.
26. H genes of B cells from cerebrospinal fluid in multiple sclerosis. J. Clin. Invest. 102: 1045-1050.
27. Colombo, M., M. Dono, P. Gazzola, S. Roncella, A. Valetto, N. Chiorazzi, G. L. Mancardi, and M. Ferrarini. 2000. Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J. Immunol. 164: 2782-2789.
28. Haase, C. G., J. Guggenmos, U. Brehm, M. Andersson, T. Olsson, M. Reindl, J. M. Schneidewind, U. K. Zettl, F. Heidenreich, T. Berger, et al. 2001. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J. Neuroimmunol. 114: 220-225.
29. Von Budingen, H. C., S. L. Hauser, A. Fuhrmann, C. B. Nabavi, J. I. Lee, and C. P. Genain. 2002. Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination. Proc. Natl. Acad. Sci. USA 99: 8207-8212.
30. Bourquin, C., A. Iglesias, T. Berger, H. Wekerle, and C. Linington. 2000. Myelin oligodendrocyte glycoprotein-DNA vaccination induces antibody-mediated autoaggression in experimental autoimmune encephalomyelitis. Eur. J. Immunol. 30: 3663-3671.
31. Brehm, U., S. J. Piddlesden, M. V. Gardinier, and C. Linington. 1999. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG). J. Neuroimmunol. 97: 9-15.
32. McDonald, W. I., A. Compston, G. Edan, D. Goodkin, H. P. Hartung, F. D. Lublin, H. F. McFarland, D. W. Paty, C. H. Polman, S. C. Reingold, et al. 2001. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50: 121-127.
33. Burgoon, M. P., G. P. Owens, S. Carlson, A. L. Maybach, and D. H. Gilden. 2001. Antigen discovery in chronic human inflammatory central nervous system disease: panning phage-displayed antigen libraries identifies the targets of central nervous system-derived IgG in subacute sclerosing panencephalitis. J. Immunol. 167: 6009-6014.
34. Owens, G. P., M. P. Burgoon, M. E. Devlin, and D. H. Gilden. 1997. Extraction and purification of active IgG from SSPE and MS brain. J. Virol. Methods 68: 119-125.
35. Hilton, A. A., A. J. Slavin, D. J. Hilton, and C. C. Bernard. 1995. Characterization of cDNA and genomic clones encoding human myelin oligodendrocyte glycoprotein. J. Neurochem. 65: 309-318.
36. Call, M. E., J. Pyrdol, M. Wiedmann, and K. W. Wucherpfennig. 2002. The organizing principle in the formation of the T cell receptor-CD3 complex. Cell 111: 967-979.
37. Kozak, M. 1987. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J. Mol. Biol. 196: 947-950.
38. Pham-Dinh, D., M. G. Mattei, J. L. Nussbaum, G. Roussel, P. Pontarotti, N. Roeckel, I. H. Mather, K. Artzt, K. F. Lindahl, and A. Dautigny. 1993. Myelin/Oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc. Natl. Acad. Sci. USA 90: 7990-7994.
39. Skerra, A., and A. Pluckthun. 1988. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 240: 1038-1041.
40. Glynn, P., H. M. Gilbert, J. Newcombe, and M. L. Cuzner. 1982. Analysis of immunoglobulin G in multiple sclerosis brain: quantitative and isoelectric focusing studies. Clin. Exp. Immunol. 48: 102-110.
41. Butcher, H., W. Kennette, O. Collins, J. Demoor, and J. Koropatnick. 2003. A sensitive time-resolved fluorescent immunoassay for metallothionein protein. J. Immunol. Methods 272: 247-256.
42. Ogata, A., H. Tagoh, T. Lee, T. Kuritani, Y. Takahara, T. Shimamura, H. Ikegami, M. Kurimoto, K. Yoshizaki, and T. Kishimoto. 1992. A new highly sensitive immunoassay for cytokines by dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA). J. Immunol. Methods 148: 15-22.
43. Yang, J. T., C. S. Wu, and H. M. Martinez. 1986. Calculation of protein conformation from circular dichroism. Methods Enzymol. 130: 208-269.
44. O'Connor, K. C., T. Chitnis, D. E. Griffin, S. Piyasirisilp, A. Bar-Or, S. Khoury, K. W. Wucherpfennig, and D. A. Hafler. 2003. Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions. J. Neuroimmunol. 136: 140-148.
45. Kawasaki, E., and G. S. Eisenbarth. 2000. High-throughput radioassays for autoantibodies to recombinant autoantigens. Front. Biosci. 5: E181-E190.
46. Yu, L., G. Eisenbarth, E. Bonifacio, J. Thomas, M. Atkinson, and C. Wasserfall. 2003. The second murine autoantibody workshop: remarkable interlaboratory concordance for radiobinding assays to identify insulin autoantibodies in nonobese diabetic mice. Ann. NY Acad. Sci. 1005: 1-12.
47. Sblattero, D., F. Florian, E. Azzoni, T. Zyla, M. Park, V. Baldas, T. Not, A. Ventura, A. Bradbury, and R. Marzari. 2002. The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments. Eur. J. Biochem. 269: 5175-5181.
48. Richter, W., Y. Shi, and S. Baekkeskov. 1993. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc. Natl. Acad. Sci. USA 90: 2832-2836.
49. Psaridi-Linardaki, L., A. Mamalaki, and S. J. Tzartos. 2003. Future therapeutic strategies in autoimmune myasthenia gravis. Ann. NY Acad. Sci. 998: 539-548.
50. Von Budingen, H. C., S. L. Hauser, J. C. Ouallet, N. Tanuma, T. Menge, and C. P. Genain. 2004. Epitope recognition in the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination. Eur. J. Immunol. 34: 2072-2083.
51. Breithaupt, C., A. Schubart, H. Zander, A. Skerra, R. Huber, C. Linington, and U. Jacob. 2003. Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein. Proc. Natl. Acad. Sci. USA 100: 9446-9451.
52. Katz-Levy, Y., K. L. Neville, J. Padilla, S. Rahbe, W. S. Begolka, A. M. Girvin, J. K. Olson, C. L. Vanderlugt, and S. D. Miller. 2000. Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice. J. Immunol. 165: 5304-5314.
53. Robinson, W. H., P. Fontoura, B. J. Lee, H. E. de Vegvar, J. Tom, R. Pedotti, C. D. DiGennaro, D. J. Mitchell, D. Fong, P. P. Ho, et al. 2003. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat. Biotechnol. 21: 1033-1039.
54. Olson, J. K., J. L. Croxford, M. A. Calenoff, M. C. Dal Canto, and S. D. Miller. 2001. A virus-induced molecular mimicry model of multiple sclerosis. J. Clin. Invest. 108: 311-318.
55. Rosenberg, G. A. 1990. Brain Fluids and Metabolism. Oxford University Press, New York.
56. Karni, A., R. Bakimer-Kleiner, O. Abramsky, and A. Ben-Nun. 1999. Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis. Arch. Neurol. 56: 311-315.
57. Reindl, M., C. Linington, U. Brehm, R. Egg, E. Dilitz, F. Deisenhammer, W. Poewe, and T. Berger. 1999. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain 122: 2047-2056.
58. Lindert, R. B., C. G. Haase, U. Brehm, C. Linington, H. Wekerle, and R. Hohlfeld. 1999. Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein. Brain 122: 2089-2100.
59. Berger, T., P. Rubner, F. Schautzer, R. Egg, H. Ulmer, I. Mayringer, E. Dilitz, F. Deisenhammer, and M. Reindl. 2003. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N. Engl. J. Med. 349: 139-145.
60. Lampasona, V., D. Franciotta, R. Furlan, S. Zanaboni, R. Fazio, E. Bonifacio, G. Comi, and G. Martino. 2004. Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects. Neurology 62: 2092-2094.
61. Lucchinetti, C., W. Bruck, J. Parisi, B. Scheithauer, M. Rodriguez, and H. Lassmann. 2000. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47: 707-717.